Question

A 68-year-old man with heart failure with reduced ejection fraction (LVEF 30%) due to ischaemic cardiomyopathy is clinically euvolaemic on furosemide. He is not taking any disease-modifying heart failure therapies. According to contemporary Canadian heart failure guidance, which combination best represents the core pharmacologic regimen that should be established?

Accepted Answer

ACE inhibitor or ARNI, evidence-based beta-blocker, mineralocorticoid receptor antagonist, and SGLT2 inhibitor

Answer

ACE inhibitor plus beta-blocker only

Answer

ARB plus beta-blocker plus loop diuretic

Answer

ACE inhibitor plus thiazide diuretic plus digoxin

Answer

Ivabradine plus loop diuretic only

Practice question